Valo Health Appoints Rita Kale as Chief Financial Officer
LEXINGTON, Mass.–(BUSINESS WIRE)–Valo Health, Inc. (“Valo”), a company pioneering the use of human data and AI to accelerate drug discovery and development,... Read more.
Carronade’s Nominees Present Significant Risks to Cannae Shareholders
~ Cannae’s Strategic Transformation is Accelerating Long-Term Value Creation for Shareholders ~ ~ Our Board and Governance Structure have Consistently Evolved... Read more.
Food Processors and Private Label Manufacturers Added to the Queue for Traceability Data Exchange Through the ReposiTrak Traceability Network
Food processors and manufacturers bring both ingredient suppliers and customers to the list of companies preparing for traceability data sharing with ReposiTrak... Read more.
D-Wave Announces Formation of U.S. Government Business Unit
Seasoned government contracting leader, Jack Sears Jr., to lead efforts to meet growing U.S. government demand for D-Wave’s quantum computing solutions PALO ALTO,... Read more.
Genomic Testing Cooperative (GTC) to Share 12 Ground-breaking Abstracts at the 2025 American Society of Hematology (ASH) Annual Meeting in Orlando
LAKE FOREST, Calif.–(BUSINESS WIRE)–Genomic Testing Cooperative (GTC), a leading provider of integrated DNA and RNA next-generation sequencing (NGS)... Read more.
Spire Global Selected by GIST Research to Provide Soil Moisture Data for Climate and Conflict Early Warning Research in Ethiopia’s Somali Region
Supported by the International Organization for Migration (IOM), the project uses satellite-based soil moisture insights to strengthen early warning systems in one... Read more.
CI Financial Corp. Announces Private Offering of Euro Notes
TORONTO–(BUSINESS WIRE)–#CIFinancial–CI Financial Corp. (“CI” or the “Company”) today announced that it intends, subject to market and... Read more.
Primecore Announces 100 Jobs Over the Next Three Years
New investment and leadership team to drive international expansion DUBLIN–(BUSINESS WIRE)–Primecore, a program management consultancy serving the science... Read more.
Egle Therapeutics Initiates Phase 1 Healthy Volunteer Study of EGL-003, a Next Generation Treg IL-2 Agonist for Atopic Dermatitis
PARIS–(BUSINESS WIRE)–#IL2mutein–Egle Therapeutics SAS (Egle), a clinical-stage biotechnology company developing precision medicines that modulate... Read more.
Imvax Announces Positive Top-line Data from Phase 2b Clinical Trial of IGV-001 in Newly Diagnosed GBM
– Study data suggests IGV-001 provides patients with a clinically meaningful improvement in overall survival (+6.3 months; +45%) compared to the current standard... Read more.